IOL Chemicals to Meet Investors at 360 ONE Capital Conference on May 29
IOL Chemicals will attend the 360 ONE Capital Investor Conference on May 29, 2026, in Mumbai. Management will hold meetings to discuss past financial results and public information. No UPSI will be disclosed during the event.
This is a standard investor relations activity and does not involve any new material information that would significantly impact the company's stock or business operations.
The announcement is a routine intimation about an investor meeting, with no new financial or strategic information provided. Discussions are limited to publicly available data.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has announced its participation in the 360 ONE Capital (B&K) 16th Annual Investor Conference - TRINITY INDIA 2026. The event is scheduled to take place on Friday, 29th May 2026, from 10:00 AM to 5:00 PM at the Grand Hyatt, Mumbai.
During the conference, the company's management will engage in one-on-one and group meetings with investors and analysts. The discussions will be restricted to the company's past financial performance and publicly available information, ensuring no unpublished price-sensitive information (UPSI) is disclosed. The schedule is subject to change due to unforeseen circumstances, and the information will also be available on the company's website, www.iolcp.com.
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under investor meet intimation. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.